The NAD+ 1000mg & Retatrutide: The UK Breakthrough in Metabolic Health
Emerging data from the UK are generating considerable interest surrounding the potential synergy of high-dose NAD+ supplementation (1000mg) and the novel GLP-1 receptor agonist, Retatrutide. This unique approach aims to address multiple facets of metabolic imbalance , potentially offering a notew